Drawing for XT

USPTO serial 87937191

XT

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
IN, SUNG HYUN
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with XT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Alexandra MacKay

Alexandra MacKay STITES & HARBISON, PLLC401 COMMERCE STREETSUITE 800NASHVILLE, TN 37219

Goods and services

ClassDescriptionStatusFirst use
001Reagents for use in scientific research; reagents for use in scientific screening; genetic testing kits comprised of reagents for medical purposes; genetic testing kits comprised of reagents for medical purposes for animalsACTIVE—
005Reagents for use in veterinary and medical diagnostic tests; reagents for use in medical and veterinary research; diagnostic reagents for use in medical and veterinary screening; diagnostic reagents for medical and veterinary diagnostic purposes for use in assays of biological samples, particularly blood; diagnostic reagents for medical and veterinary diagnostic purposes for use in assays of samples, particularly blood; diagnostic preparations for medical and veterinary diagnostic purposes for use in relation to food intolerance testing; pharmaceutical substances based on affinity reagents equivalent to antibodies, and products comprising them, all for use in medical and/or veterinary screening; pharmaceutical preparations in the nature of antigens for medical diagnostic and veterinary diagnostic use and/or pharmaceutical purposes for the detection of diseases, allergies, infections, disorders and for immunity testing; diagnostic and/or pharmaceutical preparations containing antigens for use in medical and veterinary treatment; pharmaceutical preparation in the nature of substrates impregnated with or carrying antigens for medical diagnostic use and veterinary diagnostic use and and/or pharmaceutical purposes for the detection of diseases, allergies, infections, disorders and for immunity testing; affinity reagents equivalent to antibodies for medical diagnostic use and veterinary diagnostic use and/or pharmaceutical purposes for the detection of diseases, allergies, infections, disorders and for immunity testing; pharmaceutical or diagnostic preparations containing affinity reagents equivalent to antibodies for medical diagnostic use and veterinary diagnostic use; pharmaceutical preparations in the nature of substrates impregnated with or carrying affinity reagents equivalent to antibodies medical diagnostic use and veterinary diagnostic use; wound dressings; medical plasters; antiseptic wipes; diagnostic reagents for medical use containing any of the aforesaid products; food intolerance test kits comprising diagnostic test patches for application to the skin for determining allergiesACTIVE—
010Genetic testing kits comprised of reagents for medical purposes; genetic testing kits comprised of reagents for medical purposes for animalsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Apr 4, 2022MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 4, 2022ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 27, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 25, 2021EX4GSOU EXTENSION 4 GRANTED—
Aug 25, 2021EXT4SOU EXTENSION 4 FILED—
Aug 25, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 3, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 1, 2021EX3GSOU EXTENSION 3 GRANTED—
Mar 1, 2021EXT3SOU EXTENSION 3 FILED—
Mar 1, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 5, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 3, 2020EX2GSOU EXTENSION 2 GRANTED—
Sep 3, 2020EXT2SOU EXTENSION 2 FILED—
Sep 3, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 29, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 21, 2020EX1GSOU EXTENSION 1 GRANTED—
Feb 21, 2020EXT1SOU EXTENSION 1 FILED—
Feb 21, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 21, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 21, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 21, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 21, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Feb 21, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 3, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 9, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 9, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 19, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 3, 2019FIXDELECTRONIC RECORD REVIEW COMPLETE—
May 31, 2019ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
May 23, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 15, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 15, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 15, 2019ALIEASSIGNED TO LIE—
May 8, 2019ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Apr 10, 2019GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Apr 10, 2019GNSLLETTER OF SUSPENSION E-MAILED—
Apr 10, 2019CNSLSUSPENSION LETTER WRITTEN—
Mar 20, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 20, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 20, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 24, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 24, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 24, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 15, 2018DOCKASSIGNED TO EXAMINER—
Jun 3, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 29, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance